Pleural effusion refers to abnormal fluid accumulation within the pleural space. In normal dogs, less than 10 mL of fluid exists for lubrication. Classification by fluid type is essential for determining etiology and guiding treatment.
Overview and Clinical Importance
Pleural effusion refers to abnormal fluid accumulation within the pleural space. In normal dogs, less than 10 mL of fluid exists for lubrication. Classification by fluid type is essential for determining etiology and guiding treatment. The three major categories are purulent (pyothorax), chylous (chylothorax), and transudative effusions. Clinical recognition, proper sampling, and accurate fluid analysis are critical NAVLE skills.
High-YieldPleural effusion classification is based on total protein, nucleated cell count, and cytologic appearance. Transudates = low protein/low cells; Modified transudates = intermediate; Exudates (including pyothorax) = high protein/high cells.
| Mechanism |
Description and Examples |
| Transudation |
Altered hydrodynamic forces: increased venous hydrostatic pressure (CHF), decreased oncotic pressure (hypoalbuminemia less than 1.5 g/dL), or lymphatic obstruction |
| Exudation |
Increased capillary permeability due to inflammation, vasoactive mediators. Seen in pyothorax, FIP (cats), neoplasia |
| Vessel/Viscus Rupture |
Direct leakage: thoracic duct (chylothorax), blood vessels (hemothorax), GI tract rupture |
Pathophysiology of Pleural Effusion
Pleural fluid dynamics are governed by Starling forces. Normal pleural fluid is formed when plasma exits capillary beds in the visceral pleura. Fluid is absorbed by parietal pleural lymphatics and pulmonary capillaries.
Mechanisms of Effusion Formation
| Effusion Type |
Total Protein |
Nucleated Cells |
Gross Appearance |
| Pure Transudate |
Less than 2.5 g/dL |
Less than 1,500/uL |
Clear, colorless |
| Modified Transudate |
2.5 - 7.5 g/dL |
1,000 - 7,000/uL |
Straw-colored, slightly turbid |
| Exudate (Purulent) |
Greater than 3 g/dL |
Greater than 7,000/uL |
Turbid, foul-smelling |
| Chylous Effusion |
3.5 - 4.5 g/dL |
Less than 10,000/uL |
Milky white, opaque |
Classification of Pleural Effusions
NAVLE TipRemember the "Rule of 3s": Transudate = less than 3 g/dL protein and less than 3,000 cells/uL; Exudate = greater than 3 g/dL protein and greater than 3,000 cells/uL.
| Parameter |
Pyothorax Findings |
| Gross Appearance |
Turbid, purulent, foul-smelling (especially anaerobes), may contain flocculent material |
| Total Protein |
Greater than 3 g/dL (often greater than 5 g/dL) |
| Cytology |
Degenerate neutrophils with toxic changes, intracellular and extracellular bacteria |
| pH |
Less than 6.9 (low pH suggests pyothorax) |
| Glucose |
Less than 10 mg/dL (bacteria consume glucose) |
Pyothorax (Purulent Pleural Effusion)
Definition and Etiology
Pyothorax (thoracic empyema) is septic purulent fluid accumulation in the pleural space. In dogs, the cause is identified in only 2-22% of cases.
Common Causes in Dogs
- Migrating foreign bodies: Grass awns (hunting dogs, endemic areas)
- Penetrating wounds: Bite wounds, trauma, iatrogenic
- Extension of pneumonia: Parapneumonic effusion
- Ruptured pulmonary abscess
- Esophageal perforation
- Idiopathic (most common)
Clinical Signs
- Tachypnea, dyspnea, orthopnea (rapid, shallow breathing)
- Fever, lethargy, anorexia
- Muffled heart and lung sounds on auscultation
- Signs of sepsis: tachycardia, hypotension, altered mentation
Diagnostic Fluid Analysis
Common Bacterial Isolates
- Pasteurella species (23.3%)
- Escherichia coli (23.3%)
- Mixed anaerobes (20%) - Bacteroides, Fusobacterium
- Actinomyces/Nocardia (grass awns, higher recurrence)
Treatment of Pyothorax
High-YieldSurvival rate for pyothorax in dogs is approximately 83% with appropriate treatment. Prognosis is worse with Actinomyces/Nocardia and plant material due to higher recurrence.
| Treatment |
Details |
| Thoracic Drainage |
Bilateral thoracostomy tubes in most cases. Intermittent (q3-4h) or continuous drainage. Pleural lavage with warm saline. |
| Empirical Antibiotics |
IV broad-spectrum: Amoxicillin-clavulanate + Fluoroquinolone. Avoid aminoglycosides (poor pleural penetration). |
| Duration |
4-6 weeks minimum; continue 2 weeks beyond radiographic resolution |
| Tube Removal Criteria |
Fluid less than 2.2 mL/kg/day, no intracellular bacteria, improving radiographs |
| Surgical Indications |
Failure after 5-7 days, foreign body, lung abscess, constrictive pleuritis |
Chylothorax (Chylous Pleural Effusion)
Definition and Pathophysiology
Chylothorax is chyle accumulation due to thoracic duct or tributary leakage. Chyle contains chylomicrons (fats), lymphocytes, protein, and fat-soluble vitamins from intestinal lymphatics.
Etiology
Breed Predispositions
- Afghan Hounds (middle-aged) - High incidence
- Shiba Inu (less than 1 year)
Diagnostic Findings - Key Criteria
NAVLE TipTRIGLYCERIDES are KEY to diagnosing chylothorax! Chylous = pleural TG GREATER than serum TG. Pseudochylous = pleural TG LOWER than serum, with HIGH cholesterol.
Treatment of Chylothorax
Medical Management
Surgical Management
High-YieldChronic chylothorax can lead to FIBROSING PLEURITIS preventing lung re-expansion. This is a poor prognostic indicator and may require surgical decortication.
| Category |
Examples |
| Idiopathic (Most Common) |
No underlying cause; may involve thoracic lymphangiectasia |
| Cardiac Disease |
Right-sided heart failure, pericardial effusion, cardiomyopathy |
| Trauma |
Thoracic duct rupture (often heals spontaneously) |
| Neoplasia |
Mediastinal lymphoma, thymoma causing lymphatic obstruction |
| Other |
Heartworm disease, lung lobe torsion, diaphragmatic hernia |
Transudative Pleural Effusions
Definition and Causes
Transudates are low-protein, low-cellularity effusions from altered Starling forces (increased hydrostatic pressure, decreased oncotic pressure, or lymphatic obstruction).
Treatment
- Thoracocentesis: Only if dyspneic. Repeated drainage causes protein loss.
- CHF: Furosemide (2-4 mg/kg), ACE inhibitors, pimobendan
- Hypoalbuminemia: Treat PLN, PLE, or hepatic disease. Colloids for severe cases (short duration).
High-YieldIn hypoalbuminemic patients, AVOID excessive crystalloids - this dilutes albumin and worsens extravasation. Colloid support is preferred but only temporarily effective.
| Parameter |
Chylothorax Findings |
| Gross Appearance |
Milky white, opaque (post-prandial); may be serosanguinous if anorectic |
| Triglycerides (KEY) |
Pleural fluid triglycerides GREATER than serum (often 12-100x higher) |
| Cholesterol |
Pleural cholesterol LOWER than serum (differentiates from pseudochylous) |
| Cytology |
Predominantly small lymphocytes; chronic cases have more neutrophils/macrophages |
Thoracocentesis Procedure
Thoracocentesis is both diagnostic and therapeutic. Perform BEFORE radiographs in severely dyspneic patients - restraint for imaging may cause decompensation.
Technique
- Position: Sternal recumbency (least stressful)
- Site: 7th-9th intercostal space; ventral 1/3 for fluid, dorsal 1/3 for air
- Landmark: Insert CRANIAL to rib (vessels/nerves run on caudal border)
- Equipment: Butterfly catheter (small dogs) or over-the-needle catheter, 3-way stopcock, syringe
- Angle: 45 degrees with bevel facing lung to minimize laceration
Sample Collection
- EDTA (purple top): Cell count, cytology (preferred)
- Plain (red top): Biochemistry (triglycerides, cholesterol, glucose, pH)
- Sterile container: Aerobic and anaerobic culture
| Treatment |
Details |
| Low-Fat Diet |
Decreases triglyceride content but NOT volume. Homemade: rice + low-fat cottage cheese + calcium. |
| Rutin |
50-100 mg/kg PO TID. May decrease lymph leakage. Efficacy questionable in dogs. |
| Thoracocentesis |
As needed for respiratory compromise. Surgery indicated if taps required more than weekly. |
| Procedure |
Success Rate |
| Thoracic Duct Ligation (TDL) |
Approximately 50% alone; promotes lymphaticovenous anastomoses |
| TDL + Pericardectomy |
60-85% success; reduces venous back pressure |
| Triple Combination |
TDL + Pericardectomy + Cisterna Chyli Ablation. Highest success rates. |
| Type |
Causes |
| Pure Transudate |
Hypoalbuminemia (less than 1.5 g/dL): PLN (Labs, Goldens), PLE (Yorkies), hepatic failure |
| Modified Transudate |
CHF (right-sided most common), neoplasia (lymphatic obstruction), diaphragmatic hernia, lung lobe torsion |
| Feature |
Pyothorax |
Chylothorax |
Transudate |
| Appearance |
Turbid, foul |
Milky white |
Clear, colorless |
| Key Test |
Culture, cytology |
TG greater than serum |
Low protein/cells |
| Cytology |
Degenerate neutrophils |
Small lymphocytes |
Mesothelial cells |
| Treatment |
Drainage + antibiotics |
TDL +/- pericardectomy |
Treat underlying |
| Prognosis |
Good (83%) |
Guarded to good |
Depends on cause |